Finasteride (Propecia, Merck), an inhibitor of 5a-reductase, prevents or delays the appearance of prostate cancer by 24.8% (P<.001), according to researchers from the University of Texas Health Science Center, San Antonio, Texas.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Treatment for male pattern baldness delays prostate cancer

Newsletter